272 related articles for article (PubMed ID: 23535325)
1. Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life.
Boland E; Eiser C; Ezaydi Y; Greenfield DM; Ahmedzai SH; Snowden JA
J Pain Symptom Manage; 2013 Nov; 46(5):671-80. PubMed ID: 23535325
[TBL] [Abstract][Full Text] [Related]
2. The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study.
Ramsenthaler C; Osborne TR; Gao W; Siegert RJ; Edmonds PM; Schey SA; Higginson IJ
BMC Cancer; 2016 Jul; 16():427. PubMed ID: 27387201
[TBL] [Abstract][Full Text] [Related]
3. Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry.
van der Poel MW; Oerlemans S; Schouten HC; van de Poll-Franse LV
Ann Hematol; 2015 Apr; 94(4):651-61. PubMed ID: 25471174
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for 'late effects' screening and preventive strategies.
Samuelson C; O'Toole L; Boland E; Greenfield D; Ezaydi Y; Ahmedzai SH; Snowden JA
Hematology; 2016 Jun; 21(5):272-9. PubMed ID: 27077780
[TBL] [Abstract][Full Text] [Related]
5. Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation.
Sherman AC; Coleman EA; Griffith K; Simonton S; Hine RJ; Cromer J; Latif U; Farley H; Garcia R; Anaissie EJ
Support Care Cancer; 2003 Sep; 11(9):568-74. PubMed ID: 12827482
[TBL] [Abstract][Full Text] [Related]
6. All's well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types.
Zucca AC; Boyes AW; Linden W; Girgis A
J Pain Symptom Manage; 2012 Apr; 43(4):720-31. PubMed ID: 22277904
[TBL] [Abstract][Full Text] [Related]
7. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation.
Sherman AC; Simonton S; Latif U; Plante TG; Anaissie EJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1):12-20. PubMed ID: 19135938
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation.
Sherman AC; Simonton S; Latif U; Spohn R; Tricot G
Bone Marrow Transplant; 2004 May; 33(9):955-62. PubMed ID: 15034542
[TBL] [Abstract][Full Text] [Related]
9. Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies.
Ullrich CK; Baker KK; Carpenter PA; Flowers ME; Gooley T; Stevens S; Krakow EF; Oshima MU; Salit RB; Vo P; Connelly-Smith L; Lee SJ; Wood WA
Transplant Cell Ther; 2023 Mar; 29(3):200.e1-200.e8. PubMed ID: 36494015
[TBL] [Abstract][Full Text] [Related]
10. Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry.
Oerlemans S; Issa DE; van den Broek EC; Nijziel MR; Coebergh JW; Mols F; van de Poll-Franse LV
Eur J Haematol; 2014 Sep; 93(3):229-38. PubMed ID: 24702126
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia.
Efficace F; Breccia M; Avvisati G; Cottone F; Intermesoli T; Borlenghi E; Carluccio P; Rodeghiero F; Fabbiano F; Luppi M; Romani C; Sborgia M; D'Ardia S; Nobile F; Cantore N; Crugnola M; Nadali G; Vignetti M; Amadori S; Lo Coco F
Leukemia; 2019 Jul; 33(7):1598-1607. PubMed ID: 30573776
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support.
Gulbrandsen N; Wisløff F; Brinch L; Carlson K; Dahl IM; Gimsing P; Hippe E; Hjorth M; Knudsen LM; Lamvik J; Lenhoff S; Løfvenberg E; Nesthus I; Nielsen JL; Turesson I; Westin J;
Med Oncol; 2001; 18(1):65-77. PubMed ID: 11778972
[TBL] [Abstract][Full Text] [Related]
13. Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners.
Molassiotis A; Wilson B; Blair S; Howe T; Cavet J
Psychooncology; 2011 Jan; 20(1):88-97. PubMed ID: 20187072
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial.
Delforge M; Dhawan R; Robinson D; Meunier J; Regnault A; Esseltine DL; Cakana A; van de Velde H; Richardson PG; San Miguel JF
Eur J Haematol; 2012 Jul; 89(1):16-27. PubMed ID: 22469559
[TBL] [Abstract][Full Text] [Related]
15. Self-Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease-Modifying Treatment.
Kiely F; Cran A; Finnerty D; O'Brien T
Am J Hosp Palliat Care; 2017 Aug; 34(7):671-676. PubMed ID: 27141015
[TBL] [Abstract][Full Text] [Related]
16. Impaired health-related quality of life in acute myeloid leukemia survivors: a single-center study.
Leunis A; Redekop WK; Uyl-de Groot CA; Löwenberg B
Eur J Haematol; 2014 Sep; 93(3):198-206. PubMed ID: 24673368
[TBL] [Abstract][Full Text] [Related]
17. Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
Ahmedzai SH; Snowden JA; Ashcroft AJ; Cairns DA; Williams C; Hockaday A; Cavenagh JD; Ademokun D; Tholouli E; Allotey D; Dhanapal V; Jenner M; Yong K; Cavet J; Hunter H; Bird JM; Pratt G; Parrish C; Brown JM; Morris TCM; Cook G;
J Clin Oncol; 2019 Jul; 37(19):1617-1628. PubMed ID: 30969846
[TBL] [Abstract][Full Text] [Related]
18. Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.
Efficace F; Gaidano G; Petrucci MT; Niscola P; Cottone F; Codeluppi K; Antonioli E; Tafuri A; Larocca A; Potenza L; Fozza C; Pastore D; Rigolin GM; Offidani M; Romano A; Kyriakou C; Cascavilla N; Gozzetti A; Derudas D; Vignetti M; Cavo M
Lancet Healthy Longev; 2022 Sep; 3(9):e628-e635. PubMed ID: 36102777
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis.
Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM
Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis.
Ramsenthaler C; Kane P; Gao W; Siegert RJ; Edmonds PM; Schey SA; Higginson IJ
Eur J Haematol; 2016 Nov; 97(5):416-429. PubMed ID: 27528496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]